257 related articles for article (PubMed ID: 18560621)
21. Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships.
Leung L; Niculescu-Duvaz D; Smithen D; Lopes F; Callens C; McLeary R; Saturno G; Davies L; Aljarah M; Brown M; Johnson L; Zambon A; Chambers T; Ménard D; Bayliss N; Knight R; Fish L; Lawrence R; Challinor M; Tang H; Marais R; Springer C
J Med Chem; 2019 Jun; 62(12):5863-5884. PubMed ID: 31070916
[TBL] [Abstract][Full Text] [Related]
22. Lysyl Oxidase and the Tumor Microenvironment.
Wang TH; Hsia SM; Shieh TM
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036074
[TBL] [Abstract][Full Text] [Related]
23. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell.
Kagan HM; Li W
J Cell Biochem; 2003 Mar; 88(4):660-72. PubMed ID: 12577300
[TBL] [Abstract][Full Text] [Related]
24. Emerging Roles of Lysyl Oxidases in the Cardiovascular System: New Concepts and Therapeutic Challenges.
Martínez-González J; Varona S; Cañes L; Galán M; Briones AM; Cachofeiro V; Rodríguez C
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31615160
[TBL] [Abstract][Full Text] [Related]
25. Lysyl oxidases in mammalian development and certain pathological conditions.
Mäki JM
Histol Histopathol; 2009 May; 24(5):651-60. PubMed ID: 19283672
[TBL] [Abstract][Full Text] [Related]
26. Lysyl Oxidase: Its Diversity in Health and Diseases.
Kumari S; Panda TK; Pradhan T
Indian J Clin Biochem; 2017 Jun; 32(2):134-141. PubMed ID: 28428687
[TBL] [Abstract][Full Text] [Related]
27. Role of the lysyl oxidase enzyme family in cardiac function and disease.
Al-U'datt D; Allen BG; Nattel S
Cardiovasc Res; 2019 Nov; 115(13):1820-1837. PubMed ID: 31504232
[TBL] [Abstract][Full Text] [Related]
28. Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy.
Ye M; Song Y; Pan S; Chu M; Wang ZW; Zhu X
Pharmacol Ther; 2020 Nov; 215():107633. PubMed ID: 32693113
[TBL] [Abstract][Full Text] [Related]
29. Lysyl oxidase and endothelial dysfunction: mechanisms of lysyl oxidase down-regulation by pro-inflammatory cytokines.
Alcudia JF; Martinez-Gonzalez J; Guadall A; Gonzalez-Diez M; Badimon L; Rodriguez C
Front Biosci; 2008 Jan; 13():2721-7. PubMed ID: 17981747
[TBL] [Abstract][Full Text] [Related]
30. Metavanadate causes cellular accumulation of copper and decreased lysyl oxidase activity.
Cui CT; Uriu-Adams JY; Tchaparian EH; Keen CL; Rucker RB
Toxicol Appl Pharmacol; 2004 Aug; 199(1):35-43. PubMed ID: 15289088
[TBL] [Abstract][Full Text] [Related]
31. 2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth.
Smithen DA; Leung LMH; Challinor M; Lawrence R; Tang H; Niculescu-Duvaz D; Pearce SP; Mcleary R; Lopes F; Aljarah M; Brown M; Johnson L; Thomson G; Marais R; Springer C
J Med Chem; 2020 Mar; 63(5):2308-2324. PubMed ID: 31430136
[TBL] [Abstract][Full Text] [Related]
32. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
33. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
34. Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer.
Wang W; Wang X; Yao F; Huang C
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293126
[TBL] [Abstract][Full Text] [Related]
35. Peptides derived from the copper-binding region of lysyl oxidase exhibit antiangiogeneic properties by inhibiting enzyme activity: an in vitro study.
Mohankumar A; Renganathan B; Karunakaran C; Chidambaram S; Konerirajapuram Natarajan S
J Pept Sci; 2014 Nov; 20(11):837-49. PubMed ID: 25044713
[TBL] [Abstract][Full Text] [Related]
36. Lysyl oxidase mediates hypoxic control of metastasis.
Erler JT; Giaccia AJ
Cancer Res; 2006 Nov; 66(21):10238-41. PubMed ID: 17079439
[TBL] [Abstract][Full Text] [Related]
37. Control of lysyl oxidase activity through site-specific deuteration of lysine.
Pestov NB; Okkelman IA; Shmanai VV; Hurski AL; Giaccia AJ; Shchepinov MS
Bioorg Med Chem Lett; 2011 Jan; 21(1):255-8. PubMed ID: 21106372
[TBL] [Abstract][Full Text] [Related]
38. Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases.
Yang N; Cao DF; Yin XX; Zhou HH; Mao XY
Biomed Pharmacother; 2020 Nov; 131():110791. PubMed ID: 33152948
[TBL] [Abstract][Full Text] [Related]
39. Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.
Findlay AD; Foot JS; Buson A; Deodhar M; Jarnicki AG; Hansbro PM; Liu G; Schilter H; Turner CI; Zhou W; Jarolimek W
J Med Chem; 2019 Nov; 62(21):9874-9889. PubMed ID: 31580073
[TBL] [Abstract][Full Text] [Related]
40. Dithiocarbamates are teratogenic to developing zebrafish through inhibition of lysyl oxidase activity.
van Boxtel AL; Kamstra JH; Fluitsma DM; Legler J
Toxicol Appl Pharmacol; 2010 Apr; 244(2):156-61. PubMed ID: 20045017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
